Cabaletta Bio CABA
NASDAQ CABA
$3.46 -0.02 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

Cabaletta Bio (CABA) Other financing activities (2020 - 2025)

Cabaletta Bio (CABA) posted quarterly Other financing activities of -$183000.0 for Q3 2025, down 114.07% year-over-year from $1.3 million in Q3 2024, and down 192.89% quarter-over-quarter from $197000.0 in Q2 2025.

Analysis

Cabaletta Bio (CABA) Other financing activities (2020 - 2025) Analysis & Trends

Cabaletta Bio's Other financing activities history runs 6 years deep, the most recent figure standing at -$183000.0 for Q3 2025.

  • In Q3 2025, Other financing activities fell 114.07% year-over-year to -$183000.0; the TTM figure through Dec 2025 stood at $14000.0 (down 99.02% YoY), while the FY2025 annual figure was $14000.0, down 99.02% from the prior year.
  • Other financing activities for Q3 2025 stood at -$183000.0, down from $197000.0 in the prior quarter.
  • The five-year high for Other financing activities was $2.3 million in Q4 2023, with the low at -$980000.0 in Q2 2024.
  • The 5-year median for Other financing activities is $197000.0 (2025), against an average of $347909.1.
  • The sharpest annual moves came in 2021 and 2023: Other financing activities slumped 11300.0% in 2021, then soared 798.04% in 2023.
  • Cabaletta Bio's Other financing activities stood at -$448000.0 in 2021, then soared by 111.38% to $51000.0 in 2022, then jumped by 4388.24% to $2.3 million in 2023, then tumbled by 43.16% to $1.3 million in 2024, then tumbled by 114.07% to -$183000.0 in 2025.
  • Business Quant data shows CABA's Other financing activities at -$183000.0 in Q3 2025, $197000.0 in Q2 2025, and $1.3 million in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Cabaletta Bio 522.26 Mn 522.26 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 94,000.00
Jun 30, 2025 197,000.00
Sep 30, 2024 71,000.00
Jun 30, 2024 250,000.00
Mar 31, 2024 1.11 Mn
Dec 31, 2023 1.23 Mn
Sep 30, 2023 239,000.00
Jun 30, 2023 390,000.00
Mar 31, 2023 458,000.00
Dec 31, 2022 25,000.00
Mar 31, 2022 51,000.00
Dec 31, 2021 60,000.00
Sep 30, 2021 459,000.00
Dec 31, 2020 4,000.00